v3.25.2
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) (Unaudited) - USD ($)
$ in Thousands
Registered Direct Offering [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Registered Direct Offering [Member]
Common Stock [Member]
Registered Direct Offering [Member]
Additional Paid-in Capital [Member]
Registered Direct Offering [Member]
Retained Earnings [Member]
Registered Direct Offering [Member]
AOCI Attributable to Parent [Member]
Registered Direct Offering [Member]
ATM Offering [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
ATM Offering [Member]
Common Stock [Member]
ATM Offering [Member]
Additional Paid-in Capital [Member]
ATM Offering [Member]
Retained Earnings [Member]
ATM Offering [Member]
AOCI Attributable to Parent [Member]
ATM Offering [Member]
Common Stock and Warrant Issuance [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock and Warrant Issuance [Member]
Common Stock [Member]
Common Stock and Warrant Issuance [Member]
Additional Paid-in Capital [Member]
Common Stock and Warrant Issuance [Member]
Retained Earnings [Member]
Common Stock and Warrant Issuance [Member]
AOCI Attributable to Parent [Member]
Common Stock and Warrant Issuance [Member]
Consideration Shares [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Consideration Shares [Member]
Common Stock [Member]
Consideration Shares [Member]
Additional Paid-in Capital [Member]
Consideration Shares [Member]
Retained Earnings [Member]
Consideration Shares [Member]
AOCI Attributable to Parent [Member]
Consideration Shares [Member]
Private Placement [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Private Placement [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Retained Earnings [Member]
Private Placement [Member]
AOCI Attributable to Parent [Member]
Private Placement [Member]
Warrants Issued for Alvogen Agreement Amendment [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Warrants Issued for Alvogen Agreement Amendment [Member]
Common Stock [Member]
Warrants Issued for Alvogen Agreement Amendment [Member]
Additional Paid-in Capital [Member]
Warrants Issued for Alvogen Agreement Amendment [Member]
Retained Earnings [Member]
Warrants Issued for Alvogen Agreement Amendment [Member]
AOCI Attributable to Parent [Member]
Warrants Issued for Alvogen Agreement Amendment [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2023                                                                         3,000,000 8,391,940        
Balance at Dec. 31, 2023                                                                         $ 3 $ 8 $ 241,406 $ (253,147) $ (3) $ (11,733)
Shares issued as conversion of principal and interest for convertible note (in shares)                                                                         0 143,648        
Shares issued as conversion of principal and interest for convertible note                                                                         $ 0 $ 1 399 0 0 400
Stock issuances, net (in shares)             0 34,584         0 575,000                     0 270,000                                
Stock issuances, net             $ 0 $ 0 $ 179 $ 0 $ 0 $ 179 $ 0 $ 1 $ 1,343 $ 0 $ 1,344             $ 0 $ 0 $ 1,027 $ 0 $ 0 $ 1,027                        
Fair value allocation of warrants issued with Registered Direct offering                                                             $ 0 $ 0 $ 0 $ 0 $ 0 $ 0            
Stock-based compensation                                                                         0 0 242 0 0 242
Net loss                                                                         $ 0 $ 0 0 (6,528) 0 (6,528)
Balance (in shares) at Mar. 31, 2024                                                                         0 9,772,672        
Balance at Mar. 31, 2024                                                                         $ 0 $ 10 244,599 (259,675) (3) (15,069)
Conversion of Series A preferred stock into common stock (in shares)                                                                         (3,000,000) 300,000        
Conversion of Series A preferred stock into common stock                                                                         $ (3) $ 0 3 0 0 0
Vesting of restricted stock awards (in shares)                                                                         0 57,500        
Vesting of restricted stock awards                                                                         $ 0 $ 0 0 0 0 0
Balance (in shares) at Dec. 31, 2023                                                                         3,000,000 8,391,940        
Balance at Dec. 31, 2023                                                                         $ 3 $ 8 241,406 (253,147) (3) (11,733)
Net loss                                                                                   (14,425)
Balance (in shares) at Jun. 30, 2024                                                                         0 10,791,630        
Balance at Jun. 30, 2024                                                                         $ 0 $ 11 249,173 (267,572) (3) (18,391)
Balance (in shares) at Mar. 31, 2024                                                                         0 9,772,672        
Balance at Mar. 31, 2024                                                                         $ 0 $ 10 244,599 (259,675) (3) (15,069)
Stock issuances, net (in shares)             0 247,868         0 698,050                                                        
Stock issuances, net             $ 0 $ 0 1,228 0 0 $ 1,228 $ 0 $ 1 $ 1,913 $ 0 $ 0 $ 1,914                                                
Stock-based compensation                                                                         0 0 97 0 0 97
Net loss                                                                         $ 0 $ 0 0 (7,897) 0 (7,897)
Balance (in shares) at Jun. 30, 2024                                                                         0 10,791,630        
Balance at Jun. 30, 2024                                                                         $ 0 $ 11 249,173 (267,572) (3) (18,391)
Issuance of shares related to reverse stock split (in shares)                                                                         0 73,040        
Contract cost related to Alvogen termination (see Note 6)                                                                         $ 0 $ 0 1,336 0 0 1,336
Balance (in shares) at Dec. 31, 2024                                                                         0 14,591,505        
Balance at Dec. 31, 2024                                                                         $ 0 $ 15 255,035 (278,273) 0 (23,223)
Shares issued as conversion of principal and interest for convertible note (in shares)                                                                         0 1,009,518        
Shares issued as conversion of principal and interest for convertible note                                                                         $ 0 $ 1 2,939 0 0 2,940
Stock issuances, net (in shares) 0 1,215,278                                                                                
Stock issuances, net $ 0 $ 1 $ 3,254 $ 0 $ 0 $ 3,255                                                                        
Fair value allocation of warrants issued with Registered Direct offering                                                                         0 0 (3,255) 0 0 (3,255)
Amortization of deferred offering costs                                                                         0 0 (7) 0 0 (7)
Consideration Shares issued as a result of repricing (See Note 9) (in shares)                                     0 303,819                                            
Consideration Shares issued as a result of repricing (See Note 9)                                     $ 0 $ 0 $ 629 $ 0 $ 0 $ 629                                    
Stock-based compensation                                                                         0 0 12 0 0 12
Net loss                                                                         $ 0 $ 0 0 (5,512) 0 (5,512)
Balance (in shares) at Mar. 31, 2025                                                                         0 17,120,120        
Balance at Mar. 31, 2025                                                                         $ 0 $ 17 258,607 (283,785) 0 (25,161)
Balance (in shares) at Dec. 31, 2024                                                                         0 14,591,505        
Balance at Dec. 31, 2024                                                                         $ 0 $ 15 255,035 (278,273) 0 (23,223)
Stock issuances, net (in shares)                       399,078                                                            
Stock issuances, net                       $ 30                                                            
Net loss                                                                                   (23,092)
Balance (in shares) at Jun. 30, 2025                                                                         0 19,473,588        
Balance at Jun. 30, 2025                                                                         $ 0 $ 19 265,732 (301,366) 0 (35,615)
Balance (in shares) at Mar. 31, 2025                                                                         0 17,120,120        
Balance at Mar. 31, 2025                                                                         $ 0 $ 17 258,607 (283,785) 0 (25,161)
Shares issued as conversion of principal and interest for convertible note (in shares)                                                                         0 1,879,406        
Shares issued as conversion of principal and interest for convertible note                                                                         $ 0 $ 2 5,981 0 0 5,983
Stock issuances, net (in shares)             0 399,078                                                                    
Stock issuances, net             $ 0 $ 0 $ 1,012 $ 0 $ 0 $ 1,012                                                            
Amortization of deferred offering costs                                                                         0 0 (85) 0 0 (85)
Stock-based compensation                                                                         0 0 67 0 0 67
Net loss                                                                         $ 0 $ 0 0 (17,581) 0 (17,581)
Shares issued in exchange for services (in shares)                                                                         0 75,000        
Shares issued in exchange for services                                                                         $ 0 $ 0 150 0 0 150
Balance (in shares) at Jun. 30, 2025                                                                         0 19,473,588        
Balance at Jun. 30, 2025                                                                         $ 0 $ 19 $ 265,732 $ (301,366) $ 0 $ (35,615)